US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist

0.316
+0.004+1.41%

Close Aug 23 16:00 ET

0.315
-0.001-0.44%

Post 20:01 ET

20.68MMarket Cap-202P/E (TTM)

Lyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 324.400K	--
--	2024/Q3	-- / 315.600K	--
--	2024/Q2	598.000K / 346.200K	--
--	2024/Q1	532.000K / 345.830K	--
--	2023/Q4	146.000K / 388.800K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 324.400K--

--2024/Q3-- / 315.600K--

--2024/Q2598.000K / 346.200K--

--2024/Q1532.000K / 345.830K--

--2023/Q4146.000K / 388.800K--

Unlock Free Earnings Estimates

Open Account

Lyra Therapeutics Earnings Reports

Lyra Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:29 ET

Lyra Therapeutics | 10-Q: Q1 2024 Earnings Report

Apr 30 16:22 ET

Lyra Therapeutics | 10-K: FY2023 Annual Report

Mar 22 07:01 ET

Lyra Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 7, 2023 16:23 ET

Analyst Rating

Updated: Aug 15, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall